Local Injection of Growth Hormone for Temporomandibular Joint Osteoarthritis

Osteoarthritis (OA) of the temporomandibular joint (TMJ) elicits cartilage and subchondral bone defects. Growth hormone (GH) promotes chondrocyte growth. The aim of this study was to evaluate the efficacy of intra-articular injections of GH to treat TMJ-OA. Monosodium iodoacetate (MIA) was used to i...

Full description

Saved in:
Bibliographic Details
Published inYonsei medical journal Vol. 61; no. 4; pp. 331 - 340
Main Authors Ok, Soo-Min, Kim, Jin-Hwa, Kim, Ji-Su, Jeong, Eun-gyo, Park, Yang Mi, Jeon, Hye-Mi, Heo, Jun-Young, Ahn, Yong-Woo, Yu, Sun-Nyoung, Park, Hae Ryoun, Kim, Kyung-Hee, Ahn, Soon-Cheol, Jeong, Sung-Hee
Format Journal Article
LanguageEnglish
Published Korea (South) Yonsei University College of Medicine 01.04.2020
연세대학교의과대학
Subjects
Online AccessGet full text
ISSN0513-5796
1976-2437
1976-2437
DOI10.3349/ymj.2020.61.4.331

Cover

More Information
Summary:Osteoarthritis (OA) of the temporomandibular joint (TMJ) elicits cartilage and subchondral bone defects. Growth hormone (GH) promotes chondrocyte growth. The aim of this study was to evaluate the efficacy of intra-articular injections of GH to treat TMJ-OA. Monosodium iodoacetate (MIA) was used to induce OA in the TMJs of rats. After confirming the induction of OA, recombinant human GH was injected into the articular cavities of rats. Concentrations of GH and IGF-1 were measured in the blood and synovial fluid, and OA grades of cartilage and subchondral bone degradation were recorded by histological examination and micro-computed tomography. MIA-induced OA in the rat TMJ upregulated insulin-like growth factor-1 (IGF-1) rather than GH levels. GH and IGF-1 concentrations were increased after local injection of GH, compared with controls. Locally injected GH lowered osteoarthritic scores in the cartilage and subchondral bone of the TMJ. Intra-articular injection of GH improved OA scores in rat TMJs in both cartilage and subchondral bone of the condyles without affecting condylar bone growth. These results suggest that intra-articular injection of human GH could be a suitable treatment option for TMJ-OA patients in the future.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
https://www.eymj.org/DOIx.php?id=10.3349/ymj.2020.61.4.331
ISSN:0513-5796
1976-2437
1976-2437
DOI:10.3349/ymj.2020.61.4.331